“…[7][8][9][10] To date, a variety of materials (liposomes, polymers, gold, Fe 3 O 4 , mesoporous silica, upconversion nanoparticles, and metal-organic frameworks) [11][12][13][14][15] have been developed to construct nanocarriers for delivering various therapeutic agents like antitumor drugs, inhibitors, proteins, nucleic acids, and even probes in tumor therapy. [16][17][18] Among them, mesoporous silica nanoparticles (MSNs) have achieved increasing attention in biomedicine for tumor therapy due to their biocompatibility, mesoporous structure with large specific surface area and pore volume, and easy surface functionalization, which facilitate to deliver guest cargos. 19,20 For example, Rao et al proposed to construct a MSNs-based nanoplatform as a reactive oxygen species (ROS)-responsive magnetic resonance (MR) imaging-guided photodynamic chemotherapeutic agent (DOX-R-MSN).…”